SPONSOR
Shu Wang
Total Trials
2
Recruiting
2
Phases
N/A
Conditions studied: HER2-positive Breast Cancer
Shu Wang is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including HER2-positive Breast Cancer.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shu Wang
How many clinical trials has Shu Wang sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Shu Wang, of which 2 are actively recruiting participants. These trials cover conditions including HER2-positive Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shu Wang research focus on?
Shu Wang clinical trials span HER2-positive Breast Cancer. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Shu Wang clinical trial?
To participate in a Shu Wang trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shu Wang trials with current recruitment status updated daily.
Clinical Trials by Shu Wang
NCT06693024
Recruiting
Adjuvant Therapy With Neratinib in HER2 Positive Early Breast Cancer
HER2-positive Breast Cancer
NCT06711068
Recruiting
Adjuvant Therapy for Intermediate Risk HER2 Positive, Lymph Node Negative Early Breast Cancer With Chemotherapy Combined Target Therapy
HER2-positive Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology